Pancreatic cancer targets and uses thereof
AssigneeCelera Corporation
InventorsBruno Domon, Ian McCaffery, Vaibhav Narayan, Scott Patterson
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for diagnosing and detecting diseases associated with pancreas. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in pancreatic diseases (PCAT) and antibodies binds to PCAT. The present invention provides that PCAT is used as targets for screening agents that modulates the PCAT activities. Further, the present invention provides methods for treating diseases associated with pancreas.
Claims3
A method of diagnosing pancreatic cancer in a human, the method comprising detecting the level of golgi apparatus protein 1 in a sample from the human using a detection reagent that selectively binds to the golgi apparatus protein 1, and diagnosing said human as having pancreatic cancer when the level is elevated relative to a control golgi apparatus protein 1 level established for a non-cancerous sample, wherein the golgi apparatus protein 1 comprises SEQ ID NO:52.
Dependencies are inferred from the claim text.